Akebia Therapeutics, Inc. (FRA:AX9)
Germany
· Delayed Price · Currency is EUR 1.339
+0.043 (3.32%)
At close: Dec 5, 2025
Akebia Therapeutics Revenue
Akebia Therapeutics had revenue of $58.77M USD in the quarter ending September 30, 2025, with 57.01% growth. This brings the company's revenue in the last twelve months to $225.07M, up 32.49% year-over-year. In the year 2024, Akebia Therapeutics had annual revenue of $160.18M, down -17.70%.
Revenue (ttm)
$225.07M
Revenue Growth
+32.49%
P/S Ratio
1.83
Revenue / Employee
$1.24M
Employees
181
Market Cap
351.29M EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 160.18M | -34.44M | -17.70% |
| Dec 31, 2023 | 194.62M | -97.86M | -33.46% |
| Dec 31, 2022 | 292.48M | 80.83M | 38.19% |
| Dec 31, 2021 | 211.65M | -82.99M | -28.17% |
| Dec 31, 2020 | 294.64M | -40.36M | -12.05% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| SAP SE | 36.49B |
| Siemens Aktiengesellschaft | 78.91B |
| Allianz SE | 105.02B |
| Deutsche Telekom AG | 121.02B |
| Siemens Energy AG | 39.08B |
| Rheinmetall AG | 11.00B |
| Münchener Rückversicherungs-Gesellschaft Aktiengesellschaft in München | 62.10B |
| Deutsche Bank Aktiengesellschaft | 29.86B |